ATHA Secures Global Rights and Major Financing for Lasofoxifene—Aiming to Transform Metastatic Breast Cancer Care
Market Chameleon (Thu, 18-Dec 9:51 AM)
Athira Pharma’s Lasofoxifene Acquisition Signals Ambitious Phase 3 Plans—and a $236 Million Financial Boost
Market Chameleon (Thu, 18-Dec 7:28 AM)
